Immix Biopharma
Los Angeles · Founded 2012
About Immix Biopharma
Immix Biopharma is a biotech company that develops treatments for cancer and other inflammation-driven diseases.
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1M – $10M
- Total funding: $124.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: nasdaq:IMMX
- Website: http://www.immixbio.com
- Phone: (888) 958-1084
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/immix-biopharma-122848 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.